Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

SURMOUNT-4

Eli Lilly · Phase 3 · Completed · Enrollment 783

NCT04660643

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Tirzepatide (lead-in)278 participants128 participants165 participantsn/r1
Tirzepatide MTD27 participants18 participants36 participantsn/r1
Placebo9 participants4 participants16 participantsn/r1

A count stays a count. This page does not turn a count into a percent.